Skip to main content

Advertisement

Table 4 Treatment and follow-up of 126 patients with neuroendocrine carcinoma of the breast in China

From: Neuroendocrine carcinoma of the breast: a review of 126 cases in China

Treatment and follow-up No. of cases (%)
Surgery
 Mastectomy 100 (79.4)
 Breast-conserving surgery 18 (14.3)
 Other breast surgery 7 (5.5)
 No surgery (chemotherapy alone) 1 (0.8)
 Axillary lymph node dissection 104 (82.5)
Neoadjuvant therapy
 Received 4 (3.2)
 None 122 (96.8)
Adjuvant therapy
 Chemotherapy 55 (43.7)
  Infiltrative ductal carcinoma of the breast regimen 53 (42.1)
  Small cell carcinoma regimen 2 (1.6)
 Radiotherapy 22 (17.5)
 Endocrine therapy 80 (63.5)
  Tamoxifen 71 (56.3)
  Aromatase inhibitors 4 (3.2)
  Tamoxifen followed by aromatase inhibitors 1 (0.8)
  Regimen not mentioned 4 (3.2)
Follow-up
 Alive without tumor 101 (80.2)
 Alive with tumor 9 (7.1)
 Died of disease 7 (5.6)
 Died of other causes 1 (0.8)
 Lost to follow-up 8 (6.3)